Home > Financial Ratios > NATCO PHARMA
AD     Remove this Ad

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 5.359.7111.3063.7525.37

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 5.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar20255.35
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2025 5.35
-44.90
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,700.5 Cr 10.7% 18.3% 21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

18.3%

21.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses